SERUM MATRIX METALLOPROTEINASE-9 LEVELS AND CARDIOVASCULAR RISK RATES IN SUBJECTS WITH METABOLIC SYNDROME


Creative Commons License

Serin S. O. , Okuturlar Y. , Gedikbasi A., Demir E., Utku I., Kocoglu H., et al.

ACTA MEDICA MEDITERRANEA, cilt.31, ss.1271-1276, 2015 (SCI İndekslerine Giren Dergi) identifier identifier

  • Cilt numarası: 31
  • Basım Tarihi: 2015
  • Dergi Adı: ACTA MEDICA MEDITERRANEA
  • Sayfa Sayısı: ss.1271-1276

Özet

Introduction: The present study aimed to evaluate and to compare Framingham Risk Score (FRS), a prediction tool for 10 year risk of coronary heart disease, and Matrix Metalloproteinase-9 (MMP-9) levels (an atherosclerotic proinflammatory marker) in patients with metabolic syndrome (MetS).